Quantcast

Latest Prostate cancer Stories

2014-06-09 12:29:27

LONDON, June 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Japanese Urological Devices Markethttp://www.reportbuyer.com/pharma_healthcare/medical_supplies/hospital_supplies/japanese_urological_devices_market.html In 2012, the Japanese market for urological devices was valued at $411.9 million.This report analyzes the markets for the treatment of benign prostate hyperplasia (BPH), prostate cancer, urinary incontinence as well as urinary and kidney...

2014-06-09 08:28:48

IBA to Manufacture and Supply 89Zr-Df-IAB2M for Multi-Center Studies in the US LOS ANGELES and DULLES, Va., June 9, 2014 /PRNewswire/ -- ImaginAb, Inc. (ImaginAb) and IBA Molecular North America, Inc. (IBA Molecular) announced that IBA Molecular has been selected to provide radiochemistry manufacturing and clinical distribution of (89)Zr-Df-IAB2M, an immunoPET tracer for imaging prostate cancer, to support multi-center clinical studies in the US. IBA Molecular will manufacture...

2014-06-06 12:24:27

SANTA MONICA, Calif., June 6, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT(TM)) products for cancer, today announced that it has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) to certain intellectual property related to T Cell Receptor (TCR)-based product candidates that target the NY-ESO-1 antigen for the treatment of cancers expressing...

2014-06-06 08:24:52

Initial clinical experience with 89Zr-labeled anti-PSMA minibody presented LOS ANGELES, June 6, 2014 /PRNewswire/ -- ImaginAb, Inc., in collaboration with Memorial Sloan-Kettering Cancer Center (MKSCC), will be presenting initial clinical data with an anti-PSMA recombinant antibody fragment (a "minibody") derived from the huJ591 monoclonal antibody, in patients with metastatic prostate cancer. The presentation of this initial data coincides with the Company's preparation to expand...

2014-06-04 16:26:11

QUEBEC CITY, June 4, 2014 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR) (OTCQX: DGCRF) (the "Corporation") today reported financial and operational results for the second quarter 2014 ended April 30, 2014. The Corporation announced a net loss of $536,597 or $0.01 per share for this quarter compared with a loss of $849,344 or $0.02 per share for the same period last year. During the second quarter ended April 30, 2014, total revenues decreased by 21% compared with the same quarter of...

2014-06-04 12:29:56

BETHESDA, Md., June 4, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that Linda F. Powers, CEO, will present at the Jefferies 2014 Global Healthcare Conference, which is being held in New York. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO NW Bio's presentation will take place on Wednesday, June 4, at 2:00 p.m. EDT in Ballroom 5 at the...

2014-06-04 12:29:19

Skyline Radiation Oncology, first in state to use Clarity, now also offers precise stereotactic radiotherapy for prostate cancer due to increased disease targeting confidence TUSTIN, Calif., June 4, 2014 /PRNewswire/ -- Skyline Radiation Oncology's acquisition of Elekta's Clarity® soft tissue visualization system is enabling physicians to continuously track the motion of the prostate during the delivery of radiation therapy. With continuous intrafractional image guidance, Skyline is...

2014-06-04 12:25:59

CRANFORD and STONE HARBOR, N.J., June 4, 2014 /PRNewswire/ -- It is estimated that 1 man in 6 will be diagnosed with prostate cancer in his lifetime, so why aren't more men talking about it? Patrick Walsh author of Still Smiling A Conversation With A Prostate Cancer Survivor (available on amazon.com) thinks he knows the answer - fear and ignorance. In Still Smiling, Walsh a prostate cancer survivor takes aim at these mindsets by telling the story of his journey through fear and ignorance and...

2014-06-03 23:17:27

DiaperBuys, a national online retailer of incontinence supplies, is celebrating Men’s Health Month throughout the month of June with special savings on products especially designed to help males who suffer from incontinence. Wixom, MI (PRWEB) June 03, 2014 DiaperBuys, a national online retailer of incontinence supplies, is celebrating Men’s Health Month throughout the month of June with special savings on products especially designed to help males who suffer from incontinence. While...

2014-06-03 23:14:11

EnergyFirst ProEnergy is being used in a University of Southern California prostate cancer study to see if EnergyFirst’s whey protein isolate powder can restore muscle mass, build strength and provide immune system support to patients. Manhattan Beach, CA (PRWEB) June 03, 2014 EnergyFirst, a world leader in nutraceuticals and nutrition supplementation, is part of a clinical trial involving the effects of whey protein powder and resistance training on patients that are in the process of...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related